4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > 脂肪原/熊去氧胆酸/AG-CN2-0411-G001/1克
商品详细脂肪原/熊去氧胆酸/AG-CN2-0411-G001/1克
脂肪原/熊去氧胆酸/AG-CN2-0411-G001/1克
脂肪原/熊去氧胆酸/AG-CN2-0411-G001/1克
商品编号: AG-CN2-0411-G001
品牌: Adipogen Inc
市场价: ¥800.00
美元价: 480.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsUDCA;USAN;BRN3219888;NSC657950;NSC683769
ProductTypeChemical
Properties
FormulaC24H40O4
MW392.6
MerckIndex14:9889
CAS128-13-2
RTECSFZ2000000
Source/HostChemicalsSynthetic.
PurityChemicals≥95%(NMR)
AppearanceWhitetooff-whitepowder.
SolubilitySolubleinDMSO,ethanolordimethylformamide.Sparinglysolubleinwater.
IdentityDeterminedby1H-NMR.
InChiKeyRUDATBOHQWOJDD-UZVSRGJWSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage+4°C
HandlingAdviceProtectfromlight.
Protectfrommoisture.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat+4°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Endogenoushydrophilicbileacid.
  • Antioxidant.Cytoprotectiveagainstoxidativestressandcelldeath.
  • Hepatoprotectiveatcellularandmolecularlevel,includingstabilizationofmembranes.Protectshepatocytesagainstbileacid-inducedapoptosis.
  • Antiapoptoticandantinecrotic.Targetsthemitochondrialfunctionandintegrity,reductionofendoplasmaticstressandinteractionswithsurvivalsignalsincAMP,Akt,NF-κB,MAPKandPI3Ksignalingpathways.
  • Modulatorandfinetunerofthep53-Mdm-2complex.
  • Chemopreventiveagainstcolorectalcancerbycounteringthetumor-promotingeffectsofsecondarybileacids.Showsalsoeffectsonepidermalgrowthfactorreceptor(EGFR)signalingandCOX-2expression.
  • Immunomodulatorandanti-inflammatorycompound.ModifiesTLR4andTLR9signalingpathwaysanddownregulatestheproductionofproinflammatorytumornecrosisfactor-α(TNF-α).
  • PregnaneXreceptoragoNIST.
  • Neuroprotective.Inhibitsneuronalapoptosis.
  • GlucocorticoidReceptor(GR)agonist.
  • Anticholestaticagent.Usedtoreducecholesterolabsorptionandforcholesterolgallstonedissolution.
  • Usedtotreatprimarybiliarycirrhosis(PBC).
  • Interfereswiththeprogressionofnon-alcoholicfattyliverdisease(NAFLD)/NASH.
  • ReducesCXCR3expression[11].
  • TIMP-1inducer[12].
  • ADAM17inhibitor[12].
ProductReferences
  1. Antioxidantpropertiesofursodeoxycholicacid:D.Lapenna,etal.;Biochem.Pharmacol.64,1661(2002)(Review)
  2. Ursodeoxycholicacidincholestaticliverdisease:mechanismsofactionandtherapeuticuserevisited:G.Paumgartner,etal.;Hepatology36,525(2002)(Review)
  3. Nonalcoholicfattyliverdisease:anoverviewofcurrentinsightsinpathogenesis,diagnosisandtreatmen.T.C.Schreuder,etal.;WorldJ.Gastroenterol.14,2474(2008)(Review)
  4. p53andtheregulationofhepatocyteapoptosis:implicationsfordiseasepathogenesis:J.D.Amaral,etal.;TrendsMol.Med.15,531(2009)(Review)
  5. Bileacids:regulationofapoptosisbyursodeoxycholicacid:J.D.Amaral,etal.;J.Lipid.Res.50,1721(2009)(Review)
  6. Bileacidsasregulatorsofhepaticlipidandglucosemetabolism:M.Trauner,etal.;Dig.Dis.28,220(2010)(Review)
  7. Targetingthep53pathwayofapoptosis:J.D.Amaral,etal.;Curr.Pharm.Des.16,2493(2010)(Review)
  8. Ursodeoxycholicacidandchemopreventionofcolorectalcancer:L.Serfaty,etal.;Gastroenterol.Clin.Biol.34,516(2010)(Review)
  9. Ursodeoxycholicacidandbile-acidmimeticsastherapeuticagentsforcholestaticliverdiseases:anoverviewoftheirmechanismsofaction:R.Poupon;Clin.Res.Hepatol.Gastroenterol.36,S3(2012)(Review)
  10. Ursodeoxycholicacidincholestasis:linkingactionmechanismstotherapeuticapplications:M.G.Roma,etal.;Clin.Sci.(Lond).121,523(2011)(Review)
  11. CXCR3axisinpatientswithprimarybiliarycirrhosis:apossIBLenovelmechanismoftheeffectofursodeoxycholicacid:P.Manousou,etal.;Clin.Exp.Immunol.172,9(2013)
  12. LiverprotectiveeffectofursodeoxycholicacidincludesregulationofADAM17activity:H.Buryova,etal.;BMCGastroenterol.13,155(2013)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。